SCHEMBL13494166

SCHEMBL13494166

O=C(ON1C(=O)CCC1=O)c1cc2cc(Cl)c(O)cc2oc1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 8/20 0.41
▸ KDM4E B2RXH2 4/20 0.39
▸ NOD2 Q9HC29 1/20 0.39
▸ MAOB P27338 2/20 0.38
▸ MIF P14174 1/20 0.38
▸ PFKFB3 Q16875 1/20 0.38
▸ MAOA P21397 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ F2 P00734 1/20 0.37
▸ CA12 O43570 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ PPARG P37231 1/20 0.36
▸ NCOA2 Q15596 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ NCOR2 Q9Y618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31114267 0.85 GPR35 (0.44) GPR35KDM4ENOD2MAOBMIF
SCHEMBL12038288 0.85 KDM4E (0.49) KDM4EMAOBMEN1KMT2AF2
SCHEMBL12038303 0.80 MAOB (0.40) KDM4EMAOBMIFPFKFB3MAOA
SCHEMBL13494173 0.80 RAB9A (0.50) KDM4EMEN1KMT2AHSD17B10ALDH1A1
SCHEMBL30267413 0.80 MIF (0.60) KDM4EMAOBMIFPFKFB3MAOA
SCHEMBL591197 0.80 MIF (0.60) KDM4EMAOBMIFPFKFB3MAOA
SCHEMBL13494164 0.79 KDM4E (0.57) GPR35KDM4ENOD2MAOBMIF
SCHEMBL14039317 0.78 KMT2A (0.45) KDM4EMAOBMAOAMEN1KMT2A
SCHEMBL14405916 0.78 KDM4E (0.54) GPR35KDM4ENOD2MAOBMIF
SCHEMBL16985170 0.78 MCL1 (0.49) KDM4EMEN1KMT2AHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11175204-B1 7-hydroxycoumarin-based cell-tracking reagents Life Technologies Corporation (US) 2021-11-16 — — US disclosed
US-9400273-B1 7-hydroxycoumarin-based cell-tracking reagents Life Technologies Corporation (US) 2016-07-26 — — US disclosed
US-9400273-B1 7-hydroxycoumarin-based cell-tracking reagents Life Technologies Corporation (US) 2016-07-26 — — US disclosed
US-20100029017-A1 Mono-chlorinated hydroxycoumarin conjugates BECTON, DICKINSON AND COMPANY 2010-02-04 — — US disclosed
US-20100029017-A1 Mono-chlorinated hydroxycoumarin conjugates BECTON, DICKINSON AND COMPANY 2010-02-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029017-A1 Mono-chlorinated hydroxycoumarin conjugates CLSPN, CLTC, HACD3 GPR35 3783/4885KDM4E 2368/4885NOD2 1924/4885
US-11175204-B1 7-hydroxycoumarin-based cell-tracking reagents MKI67, DCX, CDK7 GPR35 3017/4885KDM4E 2525/4885NOD2 4833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback